Leerink Partnrs Brokers Lift Earnings Estimates for CLOV
Clover Health Investments, Corp. (NASDAQ:CLOV – Free Report) – Investment analysts at Leerink Partnrs lifted their Q2 2026 EPS estimates for Clover Health Investments in a research report issued to clients and investors on Wednesday, May 7th. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings per share of $0.06 for […]
